XML 51 R30.htm IDEA: XBRL DOCUMENT v3.23.3
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
September 30, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$554.5 $266.4 $— $820.9 
Available-for-sale investments:
Corporate debt securities
— 718.7 — 718.7 
Asset-backed securities
— 219.7 — 219.7 
United States government and agency securities— 79.6 — 79.6 
Municipal securities
— 2.6 — 2.6 
Investments held for deferred compensation plans123.0 — — 123.0 
Derivatives— 89.3 — 89.3 
$677.5 $1,376.3 $— $2,053.8 
Liabilities    
Derivatives$— $6.7 $— $6.7 
Other— — 10.3 10.3 
$— $6.7 $10.3 $17.0 
December 31, 2022    
Assets    
Cash equivalents$280.4 $— $— $280.4 
Available-for-sale investments:
Corporate debt securities
— 980.3 — 980.3 
Asset-backed securities
— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities
— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$429.6 $1,509.4 $— $1,939.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other— — 14.0 14.0 
$— $27.2 $40.2 $67.4 
Schedule of Changes in Fair Value of Contingent Consideration and Other Liability The following tables summarize the changes in fair value of Level 3 financial instruments measured at fair value on a recurring basis (in millions):
 Contingent ConsiderationOtherTotal
Balance at December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)(3.7)(29.9)
Balance at September 30, 2023$— $10.3 $10.3 
Contingent ConsiderationOtherTotal
Balance at December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(36.3)— (36.3)
Balance at September 30, 2022$25.7 $14.0 $39.7